Search details
1.
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients.
J Clin Virol
; 165: 105519, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37321150
2.
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis.
Transplant Cell Ther
; 28(4): 211.e1-211.e9, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35042012
3.
Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
J Clin Virol
; 135: 104734, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33476929
4.
Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Haematologica
; 93(2): 248-56, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18245650
5.
Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients.
New Microbiol
; 30(3): 255-8, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17802904
6.
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
Transplantation
; 81(8): 1087-92, 2006 Apr 27.
Article
in English
| MEDLINE | ID: mdl-16641591
7.
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report.
Leuk Lymphoma
; 58(11): 2770-2771, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28287281
Results
1 -
7
de 7
1
Next >
>>